JP2012523573A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012523573A5 JP2012523573A5 JP2012505086A JP2012505086A JP2012523573A5 JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5 JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5
- Authority
- JP
- Japan
- Prior art keywords
- diagnostic method
- disease
- antibiotics
- administration
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002405 diagnostic procedure Methods 0.000 claims 10
- 229940064005 Antibiotic throat preparations Drugs 0.000 claims 8
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 claims 8
- 229940042052 Antibiotics for systemic use Drugs 0.000 claims 8
- 229940042786 Antitubercular Antibiotics Drugs 0.000 claims 8
- 229940093922 Gynecological Antibiotics Drugs 0.000 claims 8
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 claims 8
- 239000003242 anti bacterial agent Substances 0.000 claims 8
- 230000003115 biocidal Effects 0.000 claims 8
- 229940079866 intestinal antibiotics Drugs 0.000 claims 8
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 claims 8
- 108010048233 Procalcitonin Proteins 0.000 claims 5
- CWCXERYKLSEGEZ-KDKHKZEGSA-N Procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 claims 5
- 201000009910 diseases by infectious agent Diseases 0.000 claims 5
- 238000004393 prognosis Methods 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 4
- 230000002411 adverse Effects 0.000 claims 3
- 108010078762 Protein Precursors Proteins 0.000 claims 2
- 102000014961 Protein Precursors Human genes 0.000 claims 2
- 206010003816 Autoimmune disease Diseases 0.000 claims 1
- 210000001124 Body Fluids Anatomy 0.000 claims 1
- 206010007556 Cardiac failure acute Diseases 0.000 claims 1
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 208000008787 Cardiovascular Disease Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 201000008779 central nervous system disease Diseases 0.000 claims 1
- 201000006233 congestive heart failure Diseases 0.000 claims 1
- 201000010238 heart disease Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09157886 | 2009-04-14 | ||
EP09157886.4 | 2009-04-14 | ||
PCT/EP2010/002279 WO2010118855A1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012523573A JP2012523573A (ja) | 2012-10-04 |
JP2012523573A5 true JP2012523573A5 (ru) | 2012-11-15 |
JP5650718B2 JP5650718B2 (ja) | 2015-01-07 |
Family
ID=40886944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012505086A Active JP5650718B2 (ja) | 2009-04-14 | 2010-04-14 | プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 |
Country Status (15)
Country | Link |
---|---|
US (3) | US9046532B2 (ru) |
EP (1) | EP2419741B1 (ru) |
JP (1) | JP5650718B2 (ru) |
CN (2) | CN102395888B (ru) |
CY (1) | CY1122202T1 (ru) |
DK (1) | DK2419741T3 (ru) |
ES (1) | ES2751105T3 (ru) |
HK (1) | HK1221766A1 (ru) |
HR (1) | HRP20191862T1 (ru) |
HU (1) | HUE046182T2 (ru) |
LT (1) | LT2419741T (ru) |
PL (1) | PL2419741T3 (ru) |
PT (1) | PT2419741T (ru) |
SI (1) | SI2419741T1 (ru) |
WO (1) | WO2010118855A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5945063B2 (ja) * | 2012-04-12 | 2016-07-05 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 慢性心不全が疑われる患者における有害事象の予後 |
CN105528511A (zh) * | 2014-10-25 | 2016-04-27 | 潘一琦 | 一种远程诊疗对比式问诊方法及其系统 |
CN107301319B (zh) * | 2017-06-26 | 2021-02-26 | 济南市儿童医院 | 儿科临床及科研中抗菌药物使用危险评估系统 |
WO2019122088A1 (en) * | 2017-12-20 | 2019-06-27 | B.R.A.H.M.S Gmbh | Antibiotic therapy guidance based on procalcitonin in patients with comorbidities |
EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
DE50015156D1 (de) * | 1999-12-22 | 2008-06-26 | Dade Behring Marburg Gmbh | Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung |
DE60233949D1 (de) * | 2001-08-20 | 2009-11-19 | Biosite Inc | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon |
US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
DE102005034174A1 (de) * | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
FR2894675B1 (fr) * | 2005-12-14 | 2008-06-27 | Assist Publ Hopitaux De Paris | Distinction des meningites bacteriennes et virales |
DE102006046996A1 (de) | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
CN103123359B (zh) | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
-
2010
- 2010-04-14 EP EP10717531.7A patent/EP2419741B1/en active Active
- 2010-04-14 DK DK10717531T patent/DK2419741T3/da active
- 2010-04-14 CN CN201080016849.8A patent/CN102395888B/zh active Active
- 2010-04-14 ES ES10717531T patent/ES2751105T3/es active Active
- 2010-04-14 JP JP2012505086A patent/JP5650718B2/ja active Active
- 2010-04-14 SI SI201031945T patent/SI2419741T1/sl unknown
- 2010-04-14 PL PL10717531T patent/PL2419741T3/pl unknown
- 2010-04-14 HU HUE10717531A patent/HUE046182T2/hu unknown
- 2010-04-14 CN CN201510626744.9A patent/CN105334330A/zh active Pending
- 2010-04-14 LT LT10717531T patent/LT2419741T/lt unknown
- 2010-04-14 US US13/264,252 patent/US9046532B2/en active Active
- 2010-04-14 PT PT107175317T patent/PT2419741T/pt unknown
- 2010-04-14 WO PCT/EP2010/002279 patent/WO2010118855A1/en active Application Filing
-
2015
- 2015-03-30 US US14/672,801 patent/US9810699B2/en active Active
-
2016
- 2016-08-16 HK HK16109795.0A patent/HK1221766A1/zh unknown
-
2017
- 2017-11-06 US US15/804,282 patent/US20180052179A1/en not_active Abandoned
-
2019
- 2019-10-15 HR HRP20191862TT patent/HRP20191862T1/hr unknown
- 2019-10-24 CY CY20191101107T patent/CY1122202T1/el unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ovchinnikova et al. | Signature of circulating microRNAs in patients with acute heart failure | |
Radon et al. | Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma | |
Ferrante et al. | Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography | |
Vansteenkiste et al. | Screening and early—detection of lung cancer | |
EP3482201A1 (en) | Early diagnosis of infections | |
JP2012523573A5 (ru) | ||
Pan et al. | Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis | |
JP7277465B2 (ja) | プロカルシトニンと中間領域プロアドレノメデュリンを使用したリスク評価と患者管理のためのワークフロー | |
HRP20191862T1 (hr) | Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina | |
Seah et al. | Interleukin-4 and its alternatively spliced variant (IL-4 δ 2) in patients with atopic asthma | |
JP2007514651A5 (ru) | ||
Christ-Crain et al. | Procalcitonin and pneumonia: is it a useful marker? | |
Bernardes et al. | Myocardial perfusion in rheumatoid arthritis patients: associations with traditional risk factors and novel biomarkers | |
Langsford et al. | The association between biomarker profiles, etiology of chronic kidney disease, and mortality | |
JP2024009019A (ja) | 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス | |
JP2017519008A5 (ru) | ||
Liu et al. | Soluble glycoprotein 130 and heat shock protein 27 as novel candidate biomarkers of chronic heart failure with preserved ejection fraction | |
Ferreira et al. | Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE‐HF trial | |
Wan et al. | Plasma long noncoding RNA IL‐7R as a prognostic biomarker for clinical outcomes in patients with acute respiratory distress syndrome | |
Sun et al. | Alterations of gut fungal microbiota in patients with rheumatoid arthritis | |
Lin et al. | Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension | |
Wang et al. | Simvastatin combined with resistance training improves outcomes in patients with chronic heart failure by modulating mitochondrial membrane potential and the Janus kinase/signal transducer and activator of transcription 3 signaling pathways | |
Singh et al. | Idiopathic pulmonary fibrosis: where do we stand and how far to go | |
CA3108835A1 (en) | Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease | |
JPWO2019117269A1 (ja) | 膵がんの検出を補助する方法 |